Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 59
Filter
1.
Biomed Res Int ; 2021: 9979670, 2021.
Article in English | MEDLINE | ID: mdl-34409109

ABSTRACT

Oncotherapeutics like doxorubicin can affect male gonads; as a result, it leads to infertility. This work was conducted to demonstrate the toxic effects of doxorubicin on testes of male albino rats. Fifty male albino rats aged 5-7 weeks were used in this study. The animals were randomly separated into 5 sets (each set containing ten rats). Group I received saline (i.p.) for 4 weeks. Group II was given doxorubicin (DOX), 5 mg/kg BW (i.p.) once/week for 4 weeks. Groups III and IV were treated in the same way as the DOX group, left for one week without medication, and then injected with mesenchymal stromal cells (MSCs) or human placental extract (HPE) therapy in a single dose of 5 × 106 in 200 ml PRP/week or 40 µl placental extract for 4 weeks via the caudal vein. Group V rats were treated in the same way as the DOX group also, left for one week without medication, and then injected with MSC+HPE. A significant decrease in serum testosterone, FSH, and LH levels was observed in rats treated with DOX compared to the control group. A significant elevation was recorded in rats treated with DOX+MSC or DOX+HPE when compared with the DOX group only. Rats that were given MSC+HPE after DOX intoxication showed a significant increase in hormone levels when compared to rats treated with either MSC or HPE. Light and electron microscopic examinations revealed that DOX intoxication initiated degenerative and necrotic changes in seminiferous tubules associated with partial or complete cessation of spermatogenesis. These effects were reversed by the effect of MSC or HPE. Coadministration of MSC and HPE even showed further improvement. Finally, we can say that doxorubicin has a deleterious impact on rat testes; however, therapeutic effects can be induced through MSC and/or HPE administration.


Subject(s)
Doxorubicin/toxicity , Mesenchymal Stem Cell Transplantation/methods , Placental Extracts/administration & dosage , Testis/physiology , Animals , Combined Modality Therapy , Female , Follicle Stimulating Hormone/blood , Humans , Luteinizing Hormone/blood , Male , Mice , Placental Extracts/pharmacology , Pregnancy , Rats , Testis/drug effects , Testosterone/blood
2.
Nutrients ; 12(10)2020 Oct 11.
Article in English | MEDLINE | ID: mdl-33050586

ABSTRACT

BACKGROUND: Fatigue is one of the major health conditions induced by excessive stress or abnormal immune function or defective antioxidant systems. Placental extract has been reported to have various effects such as immune modulation and cellular regeneration. Fermented porcine placenta (FPP) is a safe nontoxic material, which is highly valuable as a functional food. The aim of this study was to investigate the anti-fatigue effects of FPP supplementation compared with a placebo product. METHODS: In this double-blind, parallel, randomized, and placebo-controlled trial 84 healthy males and females, aged between 30 and 60 years were randomized to 320 mg of FPP once daily or placebo. The main outcome measures included efficacy of fatigue-inducing treadmill exercise on physical fatigue and fatigue-related parameters based on the questionnaire administered. RESULTS: The IL-1ß mRNA expression and fatigue severity scale were changed significantly after 8 weeks of treatment with fermented porcine placenta compared with placebo (p < 0.05). Cortisol levels were significantly improved in participants younger than 45 years following treatment with FPP compared with placebo. Furthermore, the lactate and myoglobin levels were improved significantly in participants with BMI ≥ 23 kg/m2 (p = 0.045 and p = 0.011, respectively) following treatment with FPP versus placebo. CONCLUSIONS: Our study showed that FPP supplementation significantly ameliorated fatigue-related parameters and subjective symptoms in healthy adults. Therefore, our results indicate that FPP supplementation induced anti-fatigue effect by regulating the inflammatory response.


Subject(s)
Dietary Supplements , Fatigue/metabolism , Fatigue/therapy , Placental Extracts/administration & dosage , Adult , Animals , Double-Blind Method , Fatigue/genetics , Fatigue/prevention & control , Female , Fermentation , Humans , Hydrocortisone/metabolism , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Lactates/metabolism , Male , Middle Aged , Myoglobin/metabolism , Placental Extracts/pharmacology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Surveys and Questionnaires , Swine , Treatment Outcome
3.
Taiwan J Obstet Gynecol ; 59(5): 675-681, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32917317

ABSTRACT

OBJECTIVES: To determine the effect of oral administration of porcine placental extract (PPE) on the menopausal symptoms of Korean women. MATERIALS AND METHODS: This study was a multicenter, randomized double-blind placebo-controlled trial. A hundred menopausal Korean women were randomly allocated either to the PPE 400 mg per day or the control group during 12 weeks of the study period. Menopausal symptoms were evaluated using the Kupperman Index (KMI). RESULTS: The KMI decreased after 12 weeks in both groups; however, the difference in the changes was not statistically significant. Among overweight or obese women whose body mass index (BMI) was 23 kg/m2 or higher, the KMI decreased more significantly in the PPE group than placebo group after 12 weeks (-18.52 ± 9.09 vs -11.40 ± 10.68, P < 0.05). Among 49 early menopausal women whose duration of menopause was less than 3 years, the KMI decreased more significantly in the PPE group after 12 weeks (-17.29 ± 9.07 vs -11.29 ± 10.68, P < 0.05). The baseline estradiol level was not statistically different between the two groups before trial, but the estradiol level of the PPE group was significantly increased at 12 weeks (11.13 ± 35.13 pg/m, P < 0.05). CONCLUSIONS: Oral administration of 400 mg PPE per day decreases menopausal symptoms in women with BMI 23 kg/m2 or higher or in early menopausal women. PPE may be considered as a short-term complementary treatment to reduce menopausal symptoms, especially in overweight or early menopausal women.


Subject(s)
Menopause/drug effects , Placental Extracts/administration & dosage , Administration, Oral , Animals , Body Mass Index , Double-Blind Method , Female , Humans , Middle Aged , Overweight/complications , Republic of Korea , Swine
4.
Alcohol Clin Exp Res ; 44(5): 1018-1024, 2020 05.
Article in English | MEDLINE | ID: mdl-32154587

ABSTRACT

BACKGROUND: Human placenta extract (HPE) has been used to treat a number of liver diseases. Porcine placenta is relatively safe and has been reported to have similar immune effects to HPE and used as its alternative. This study evaluates the effect of enzymatic porcine placental extract (EPPE, Uni-Placenta®) on alcohol pharmacokinetics in rat. METHODS: This study was designed to determine the effect of single-dose EPPE on the pharmacokinetics of alcohol and liver function. Results were based on serum alcohol and acetaldehyde concentrations and activities of hepatic and gastric ADH and ALDH in rats. RESULTS: The hepatic ADH in alcohol group was significantly increased and it may be enzyme-induction by alcohol. The hepatic ALDH and gastric ADH were not changed, but gastric ALDH was significantly decreased only in the high-dose EPPE group. In the alcohol pharmacokinetics parameters, the AUC was 44.5 mM∙h in the alcohol group. Otherwise, AUCs of low, middle, high, and silymarin groups were significantly decreased. Cmax was reached at 1 hour and then gradually decreased to 63% and 43% in the middle and high groups at 3 hours, respectively, and to 92% in the low groups. The pharmacokinetics and serum concentrations of acetaldehyde showed no differences between EPPE groups except the silymarin group. No histologic changes were seen in any group. CONCLUSIONS: The single-dose EPPE (0.5 to 2.5 g/kg) suppressed absorption of alcohol in the gastrointestinal tract. This may be useful in preventing hangover effects and toxicity after drinking alcohol and may also preserve liver health after alcohol ingestion.


Subject(s)
Ethanol/pharmacokinetics , Liver/drug effects , Placental Extracts/administration & dosage , Acetaldehyde/blood , Alcohol Dehydrogenase/analysis , Aldehyde Dehydrogenase/analysis , Animals , Ethanol/blood , Liver/enzymology , Male , Rats , Rats, Sprague-Dawley , Stomach/enzymology , Swine
5.
Trials ; 20(1): 415, 2019 Jul 10.
Article in English | MEDLINE | ID: mdl-31291984

ABSTRACT

BACKGROUND: Hot flashes are the most frequent symptoms of the menopause, with 10-20% of all postmenopausal women reporting nearly intolerable occurrences. Although pharmacopuncture with hominis placenta extract is one of the new acupuncture therapies popular in East Asian medicine with a known efficacy in treating facial flushing, there has been little research on the efficacy and safety of this extract. This study, therefore, aims to evaluate the efficacy and safety of pharmacopuncture with hominis placenta extract (PLC) compared to injections of normal saline, in perimenopausal and postmenopausal women in Korea. METHODS/DESIGN: This study is a randomized placebo-controlled single-blind multi-center parallel-design trial. In total, 128 perimenopausal or postmenopausal women who meet the inclusion criteria will be recruited. The treatment group will receive PLC pharmacopuncture twice a week, for a total of 18 sessions over 9 weeks. The control group will receive injections of normal saline at the same acupoints during the same period. The post-treatment follow-up assessment will occur 4 weeks after the participant has completed the treatment. DISCUSSION: We believe that this trial will provide evidence for the efficacy and safety of PLC pharmacopuncture as a treatment for hot flashes in perimenopausal and postmenopausal women. TRIAL REGISTRATION: Clinical Research Information Service (CRIS), Republic of Korea, ID: KCT0003533 , Registered on 20 February 2019.


Subject(s)
Acupuncture Therapy , Hot Flashes/therapy , Perimenopause , Placental Extracts/administration & dosage , Postmenopause , Acupuncture Therapy/adverse effects , Age Factors , Female , Hot Flashes/diagnosis , Hot Flashes/physiopathology , Humans , Middle Aged , Multicenter Studies as Topic , Placental Extracts/adverse effects , Pregnancy , Randomized Controlled Trials as Topic , Republic of Korea , Single-Blind Method , Time Factors , Treatment Outcome
6.
J Invest Surg ; 32(4): 304-313, 2019 Jun.
Article in English | MEDLINE | ID: mdl-29431531

ABSTRACT

Background: Human placental extract (HPE), prepared from the placentas of healthy, postpartum females, displays various physiological activities, including antioxidative properties. In this study, a dorsal skin flap model was used to investigate the effect of HPE on flap viability in rats. Materials and methods: Forty male Sprague-Dawley rats underwent random-pattern skin flap surgeries. The animals were randomly divided among a control group and three treatment groups (localized injection (LI), 10 mg/kg/d localized HPE injections; low-dose treatment (LT), 10 mg/kg/d systemic HPE injections; high-dose treatment (HT), 40 mg/kg/d systemic HPE injections). Surviving skin flap areas were measured 7 days after surgery and tissue samples were stained with hematoxylin and eosin; vascular endothelial growth factor expression was determined immunohistochemically. To evaluate the antioxidant and antiapoptotic effects of HPE, malondialdehyde, glutathione peroxidase, and caspase-3 levels were examined. Results: Seven days after surgery, HPE-treated animals had significantly reduced necrotic areas, rats receiving the highest HPE dose demonstrated the greatest flap survival. In the HPE groups, the histopathological scores were lower than for the control group. Immunohistochemistry showed markedly more numerous vascular endothelial growth factor-positive cells in the HT group than in the C group. Malondialdehyde levels were significantly lower and glutathione peroxidase levels were higher in the HT group than in the C group. HPE treatment significantly inhibited apoptosis by lowering caspase-3 activity. Conclusions: HPE treatment yielded positive effects on flap survival, due to its antioxidant and antiapoptotic properties. These results suggest a new therapeutic approach for enhancing flap viability and accelerating wound repair.


Subject(s)
Antioxidants/administration & dosage , Graft Survival/drug effects , Placental Extracts/administration & dosage , Surgical Flaps/transplantation , Animals , Apoptosis/drug effects , Disease Models, Animal , Dose-Response Relationship, Drug , Female , Humans , Injections, Intralesional , Injections, Intraperitoneal , Male , Postpartum Period , Rats , Rats, Sprague-Dawley , Skin/drug effects , Wound Healing
7.
J Pediatr Adolesc Gynecol ; 32(1): 78-79, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30244191

ABSTRACT

BACKGROUND: Placentophagy, or the practice of placental consumption, has grown in popularity over the past decade. Although advocates endorse prevention of postpartum depression, increased breast milk production, reduction in postpartum bleeding, and provision of nutrients postpartum, scientific studies have failed to show benefit. No studies have explored the effect of placental hormone consumption on the hypothalamic-pituitary-ovarian axis of the offspring. CASE: We present a case of vaginal bleeding and breast budding in a 3-month-old infant whose mother was exclusively breastfeeding. Maternal history was notable for placentophagy. Upon discontinuation of consuming encapsulated placenta, the infant's vaginal bleeding resolved. SUMMARY AND CONCLUSION: Our case raises concerns regarding placentophagy and infant endocrine function. More research is needed to assess maternal and infant exogenous estrogen exposure with maternal placental consumption.


Subject(s)
Breast Diseases/etiology , Placental Extracts/adverse effects , Uterine Hemorrhage/etiology , Breast , Breast Feeding/adverse effects , Female , Humans , Infant , Mothers , Placenta , Placental Extracts/administration & dosage , Postpartum Period , Pregnancy
8.
Climacteric ; 20(2): 144-150, 2017 Apr.
Article in English | MEDLINE | ID: mdl-28112981

ABSTRACT

OBJECTIVES: This study assessed the effects of oral porcine placental extract (PPE) on the mild menopausal symptoms of climacteric women. METHODS: In this 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study, 50 climacteric Japanese women were randomized 1 : 1 to oral PPE (300 mg/day) or placebo. Menopausal symptoms were evaluated by using the Simplified Menopausal Index (SMI), as were serum estradiol (E2) and follicle stimulating hormone (FSH) levels. Blood biochemical and cellular and urinary tests were done to evaluate safety aspects of repeated oral administration of PPE. RESULTS: The total SMI score of the PPE group was significantly more improved after 12 weeks than that of the placebo group (p = 0.031). This score and three subscores (vasomotor, psychological, and somatic symptoms) were significantly improved at 8 and/or 12 weeks compared with the initial values in the PPE group (p < 0.05). E2 and FSH levels were not improved in either group. No adverse events were observed. CONCLUSIONS: Oral PPE at 300 mg/day improved the mild menopausal symptoms of climacteric women. Since oral PPE did not improve serum E2 and FSH levels, PPE is thought not to ameliorate hormonal balance itself but to improve subjective feelings of climacteric women.


Subject(s)
Menopause/drug effects , Placental Extracts/administration & dosage , Administration, Oral , Animals , Depression/drug therapy , Double-Blind Method , Estradiol/blood , Female , Follicle Stimulating Hormone/blood , Hot Flashes/drug therapy , Humans , Irritable Mood/drug effects , Japan , Menopause/blood , Middle Aged , Surveys and Questionnaires , Swine , Symptom Assessment/methods , Treatment Outcome
9.
J Foot Ankle Surg ; 54(6): 1193-6, 2015.
Article in English | MEDLINE | ID: mdl-26213164

ABSTRACT

Local injections of corticosteroids or human placental extracts are sometimes used for the treatment of resistant tendinitis or fasciitis. We report a case of infectious Achilles tendinitis complicated by calcaneal osteomyelitis after injection of human placental extracts for the Achilles tendinitis. She was treated with excision of the infected bone and tendon, followed by V-Y lengthening of the proximal portion of the Achilles tendon in a single stage. At 2 years postoperative, she remained symptom free without any signs of recurrence, and the follow-up magnetic resonance imaging scan demonstrated a well-maintained Achilles tendon with normal signal intensity.


Subject(s)
Abscess/surgery , Achilles Tendon/surgery , Calcaneus/surgery , Osteomyelitis/surgery , Placental Extracts/adverse effects , Tendinopathy/therapy , Abscess/etiology , Adult , Chronic Disease , Female , Humans , Injections/adverse effects , Osteomyelitis/etiology , Placental Extracts/administration & dosage , Suture Anchors , Tendinopathy/complications
10.
J Oral Maxillofac Surg ; 73(7): 1439.e1-10, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25891654

ABSTRACT

PURPOSE: Placental extract has been used as a therapeutic agent with application in various fields of medicine. Placental extract is well known for its effects on wound healing with anti-inflammatory, antiplatelet, and angiogenic effects and is also a biogenic modulator. The present study evaluated the effect of placental extract on wound healing, mouth opening, and postoperative patient discomfort in patients with oral submucous fibrosis treated with fibrotomy with buccal fat pad coverage and coronoidectomy. MATERIALS AND METHODS: Ten subjects with oral submucous fibrosis who presented with mouth opening less than 20 mm were enrolled in the present prospective randomized controlled trial to assess the effects of placental extract on the fibrotomy wound covered with a pedicled buccal pad fat (5 patients allocated to the study group, group S and 5 to the control group, group C). The following criteria were used to analyze the postoperative effect of placental extract on fibrotomy wounds compared with that of the controls: subjective assessment of the wound, postoperative discomfort, and postoperative mouth opening assessed at 1, 2, and 4 weeks postoperatively. RESULTS: The average difference in the preoperative and fourth week postoperative mouth opening for group C was 13.8 ± 2.68 mm and was 21.20 ± 2.77 mm in group S. The median calculated for group C was a 15.0-mm increase in mouth opening and was 20.0 mm in group S. CONCLUSION: The results obtained with topical application of placental extract on fibrotomy wound healing and postoperative mouth opening were superior to those of the control group in whom placental extract was not used.


Subject(s)
Mouth Mucosa/drug effects , Oral Submucous Fibrosis/surgery , Pain, Postoperative/prevention & control , Placental Extracts/therapeutic use , Trismus/surgery , Adipose Tissue/transplantation , Administration, Mucosal , Adult , Autografts/transplantation , Connective Tissue/drug effects , Connective Tissue/surgery , Epithelium/pathology , Follow-Up Studies , Gels , Granulation Tissue/pathology , Humans , Male , Mandible/surgery , Mouth Mucosa/surgery , Pain Measurement/methods , Physical Therapy Modalities , Placental Extracts/administration & dosage , Prospective Studies , Wound Healing/drug effects
11.
Toxicol Mech Methods ; 25(1): 13-20, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25266486

ABSTRACT

Placenta is an important organ that connects the developing fetus to allow nutrient uptake, antibody provisions and gas exchange via the blood supply of the mother. We developed a novel, standardized, stable, water-soluble, peptide-enriched hydrolyzed, Horus fermented placenta powder (HFPEP) from healthy, pathogen-free, swine placenta. Earlier studies demonstrated that HFPEP significantly improves physical fatigue, hepatic functions and repair of muscle fibers. We examined the broad safety of HFPEP in various toxicology models in Good Laboratory Practices-approved laboratories. The acute oral toxicity study was conducted in female Sprague-Dawley rats, and the acute oral LD50 was found to be greater than 5000 mg/kg body weight. Ames' bacterial reverse mutation assay was conducted to determine the ability of HFPEP to induce reverse mutation at selected histidine loci in five tester strains of Salmonella typhimurium viz. TA1535, TA1537, TA98, TA100 and TA102 in the presence and absence of a metabolic activation system (S9) at the doses of 50, 15, 4.5, 1.35 and 0.41 mg/ml. No mutagenic potential was observed. Mutagenic potential was also evaluated using in vivo micronucleus test, and no mutagenic potential of HFPEP was observed. Repeated dose 28-d oral toxicity study was performed in male and female rats with 14-d recovery period at the dose levels of 250, 500 or 1000 mg/kg. No abnormal clinical signs or toxicity were detected. No observed adverse effect level of HFPEP was found to be greater than 1000 mg/kg body weight. These studies affirm that HFPEP has broad spectrum safety for human consumption.


Subject(s)
Fermentation , Peptides/toxicity , Placental Extracts/toxicity , Administration, Oral , Animals , Female , Lethal Dose 50 , Male , Micronuclei, Chromosome-Defective/chemically induced , Micronucleus Tests , Mutation , No-Observed-Adverse-Effect Level , Peptides/administration & dosage , Placental Extracts/administration & dosage , Powders , Rats, Sprague-Dawley , Risk Assessment , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Swine , Time Factors
12.
J Acupunct Meridian Stud ; 7(3): 155-8, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24929460

ABSTRACT

This is a case report of a female patient who developed complex regional pain syndrome in the left upper limb after a traumatic injury to the distal part of the left forearm. The pain was immediate and resistant to oral analgesics and continued transcutaneous electrical nerve stimulation. Five months after the injury, the patient presented to our clinic with severe pain, swelling, redness, cold sensation of the left hand, and loss of function from the left hand up to the left shoulder. Acupuncture points LI5, LU2, SI10, HT1, GB21, and SI11 (which are localized in the joints or in the muscles responsible for the movement of the left upper limb) were selected for the application of the placental extract. Injection of placental extract into the acupuncture points resulted in dramatic pain relief, swelling remission, motor recovery, temperature normalization, and disappearance of redness in this patient with complex regional pain syndrome type 1.


Subject(s)
Acupuncture Points , Acupuncture Therapy , Analgesics/therapeutic use , Arm/pathology , Complex Regional Pain Syndromes/therapy , Placental Extracts/therapeutic use , Adult , Analgesics/administration & dosage , Complex Regional Pain Syndromes/drug therapy , Female , Humans , Injections , Placental Extracts/administration & dosage
13.
Climacteric ; 17(4): 370-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24313619

ABSTRACT

OBJECTIVE: Injections of human placental extract, which is known to play a role in skin regulation, have long been used for the treatment of skin wrinkles and non-healing wounds. Porcine placental extract (PPE), an oral supplement, was recently developed for this purpose. The aim of this study was to assess whether PPE has a positive effect on the improvement of fine wrinkles below the eye in climacteric women. METHODS: We first non-invasively measured wrinkle widths with a skin analyzer in a cross-section of 185 healthy adult Japanese women. Next, 44 climacteric women with mild or few climacteric symptoms were enrolled into an open-label, randomized, controlled study of the effect of PPE on wrinkle widths. A retrospective comparison of wrinkle widths in 123 climacteric women with climacteric symptoms with or without PPE treatment was also performed. RESULTS: Wrinkle widths below the eye in women ≥ 30 years of age were significantly higher than in women 20-29 years of age. Treatment with three capsules of PPE per day was significantly (p < 0.05) effective in reducing wrinkle widths at 24 weeks compared with control subjects. Retrospective analysis showed that subjects treated with three (p < 0.05) and six (p < 0.01) capsules of PPE per day observed a significant reduction in wrinkle widths compared with untreated subjects. CONCLUSION: Oral PPE treatment is a possible option for improving the appearance of fine wrinkles below the eye in climacteric women.


Subject(s)
Eyelids/pathology , Menopause , Placental Extracts , Skin Aging , Administration, Oral , Adult , Animals , Capsules , Complementary Therapies/methods , Cross-Sectional Studies , Dose-Response Relationship, Drug , Drug Monitoring , Female , Humans , Japan , Middle Aged , Placental Extracts/administration & dosage , Placental Extracts/adverse effects , Retrospective Studies , Skin Aging/drug effects , Skin Aging/pathology , Swine , Treatment Outcome
14.
Int Wound J ; 10(2): 167-76, 2013 Apr.
Article in English | MEDLINE | ID: mdl-22494419

ABSTRACT

Topical wound-healing potential of autologous bone marrow-derived nucleated cells along with placental extract was evaluated in comparison with buffy coat of autologous blood on full-thickness cutaneous wounds in the thoracolumbar region of 15 clinically healthy New Zealand rabbits. Three wounds of 2 × 2 cm, one on the right side of the body and two on the left side of the midline were created on the dorsal lumbar region of each rabbit under xylazine-ketamine anaesthesia. The wounds of each animal were randomly assigned to one of the three treatments: topical application of autologous bone marrow-derived cells with placental extract (group I), application of buffy coat in the autologous plasma with placental extract (group II) and autologous plasma with placental extract as control (group III). Wounds were observed for 30 days macroscopically and for granulation tissue formation, histomorphological and histochemical evaluation. Time of appearance of granulation tissues and filling of wound beds were faster in group I followed by group II and group III animals, respectively. Histomorphological findings exhibited an earlier disappearance of inflammatory reaction, better epithelialisation, significantly maximum neovascularisation, fibroplasias and collagenation in group I followed by group II and group III animals, respectively. Histochemical findings also depicted maximum number of robust, thick, interwoven type of collagen fibres, stout, highly tortuous and interwoven network of elastin fibres and numerous mesh war form of reticulin fibres within the dermal component were present in group I when compared with group II and III animals. Experiment conclude that single application of autologous bone marrow-nucleated cells with placental extract topically could be a novel option for faster healing in complicated non healing wounds both in human beings and animals.


Subject(s)
Macrophages/transplantation , Placental Extracts/administration & dosage , Wound Healing , Wounds and Injuries/therapy , Administration, Cutaneous , Animals , Blood Buffy Coat , Disease Models, Animal , Female , Humans , Male , Rabbits , Random Allocation , Skin/injuries , Wounds and Injuries/pathology
15.
Climacteric ; 16(4): 447-52, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23113540

ABSTRACT

OBJECTIVES: Some of the most common climacteric symptoms are somatic symptoms, such as muscle and joint pain, which cause limitations in performing daily tasks. This study aimed to assess whether oral porcine placental extract (PPE) affects patients with shoulder stiffness, one of the most common types of muscle-tendon stiffness, in climacteric women and postmenopausal women with hormone therapy (HT). METHODS: Sixty-six climacteric women (33 each in the control and study groups) with shoulder stiffness and 54 postmenopausal women (27 each in the control and study groups) with HT-resistant shoulder stiffness were enrolled into this open-label, randomized, controlled study. The control subjects received Toki-shakuyaku-san (TJ23; 7.5 g/day, daily per os), an oral herbal remedy used to alleviate climacteric symptoms, and study subjects received PPE orally for 24 weeks in climacteric women and for 12 weeks in postmenopausal women with HT. Changes in the degree of shoulder stiffness were evaluated by the Visual Analog Scale (VAS). RESULTS: Treatment with PPE was significantly effective in reducing the VAS score for shoulder stiffness during the study period compared with the control group in both climacteric and postmenopausal women with HT. The VAS score at the end of treatment was significantly reduced (p < 0.01 vs. baseline) by 76.4% for climacteric women and 64.8% for postmenopausal women with HT compared with baseline. CONCLUSIONS: PPE is useful as an oral supplement for shoulder stiffness in climacteric women without HT or in postmenopausal women with HT-resistant, long-term shoulder stiffness.


Subject(s)
Placental Extracts/administration & dosage , Postmenopause/physiology , Shoulder Joint , Shoulder Pain/drug therapy , Animals , Estrogen Replacement Therapy , Female , Humans , Middle Aged , Muscle Weakness/drug therapy , Pain Measurement , Swine
16.
J Radiat Res ; 54(2): 268-76, 2013 Mar 01.
Article in English | MEDLINE | ID: mdl-23154884

ABSTRACT

Placental extracts have been reported to have anti-oxidative and anti-inflammatory activities. Because there is increasing evidence that ionizing radiation induces the release of reactive oxygen species (ROS) and inflammatory cytokines, we examined the protective effects of a placental extract against radiation injury. C57BL/6 mice were exposed to 1 Gy of γ-ray radiation every day for 5 days, and placental extract (1 mg/day) was administrated orally soon after each exposure. At 2 days after the last irradiation, mice were euthanized to examine the numbers, colony-forming capacity, and DNA damage of stem/progenitor cells in the peripheral blood and bone marrow. To understand the related mechanisms, we also measured the levels of intracellular and mitochondrial ROS, and 8-OHdG in the plasma and urine, and IL-6 and TNF-α in the plasma. Compared with the placebo treatment, oral administration of placental extract significantly increased the number and colony-forming capacity, but decreased the DNA damage of bone marrow stem/progenitor cells. However, neither the levels of intracellular and mitochondrial ROS in bone marrow cells, nor the levels of 8-OHdG in the urine and plasma significantly differed between groups. Interestingly, in comparison with the placebo treatment, placental extract significantly decreased the levels of the inflammatory cytokines IL-6 and TNF-α in the plasma. Placental extract significantly attenuated the acute radiation injury to bone marrow-derived stem/progenitor cells, and this protection is likely to be related to the anti-inflammatory activity of the placental extract.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Cytokines/metabolism , Mesenchymal Stem Cells/metabolism , Mesenchymal Stem Cells/radiation effects , Placental Extracts/administration & dosage , Radiation Injuries/metabolism , Radiation Injuries/prevention & control , Administration, Oral , Animals , DNA Damage/drug effects , Male , Mesenchymal Stem Cells/pathology , Mice , Mice, Inbred C57BL , Radiation Injuries/pathology , Radiation-Protective Agents/administration & dosage , Reactive Oxygen Species/metabolism , Treatment Outcome
18.
In Vitro Cell Dev Biol Anim ; 48(5): 326-33, 2012 May.
Article in English | MEDLINE | ID: mdl-22549337

ABSTRACT

Intramuscular long-chain fatty acids (LCFAs) play an important role in energy production and initiation of mitochondrial oxidation of lipids. Herein, we report a natural porcine placenta steroid extract (PPSE) that stimulates transdifferentiation and lipid accumulation in bovine myogenic satellite cells (MSCs). The steroids hormones in PPSE were analyzed using enzyme-linked immunosorbant assay and presence of LCFA was established using gas chromatography. At 70% confluent growth, cells were treated with PPSE, LCFAs, transdifferentiation cocktail and commercially available steroid hormones. The working concentrations of all chemicals were manipulated similar to PPSE. The cells were observed for morphological changes and subjected to quantitative analysis of lipid deposition on Days 2, 4, and 6 of treatment. PPSE-treated MSCs exclusively transformed into lipid-accumulated adipose-like cells (ALCs). However, myotubes or adipocytes were formed in cells treated with other chemicals. Expression of different genes was studied to ascertain the molecular mechanism involved in ALC formation. CD36, fatty acid binding protein 4, and peroxisome proliferator-activated receptor-gamma were up-regulated. The expression of CD36 was established through immunocyto-chemical analysis. A viability assay was used to confirm the effect of PPSE on proliferation of MSCs. Hence, a natural steroid extract from porcine was found as a nontoxic mixture, which induces lipid accumulation and transdifferentiation of MSCs to ALCs. From the gene expression studies, it was established that the extract works almost in homogenous manner with other lipid inducers.


Subject(s)
Cell Transdifferentiation , Fatty Acids , Placental Extracts , Satellite Cells, Skeletal Muscle , Steroids , Adipocytes/cytology , Adipocytes/drug effects , Animals , Cattle , Cell Proliferation/drug effects , Cell Transdifferentiation/drug effects , Fatty Acids/administration & dosage , Fatty Acids/analysis , Female , Gene Expression Regulation , Lipid Metabolism/drug effects , Placental Extracts/administration & dosage , Placental Extracts/analysis , Satellite Cells, Skeletal Muscle/drug effects , Steroids/administration & dosage , Steroids/analysis , Swine
19.
Climacteric ; 15(1): 30-5, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22066827

ABSTRACT

OBJECTIVES: Knee pain related to osteoarthritis increases with age and is more common in middle-aged women. Although hormone replacement therapy (HRT) improves knee pain, women unresponsive to HRT need an effective adjunctive therapy. The aim of this study was to assess whether oral porcine placental extracts (PPE) have an impact on patients with knee pain as an adjunctive therapy combined with HRT. METHODS: Forty-eight postmenopausal women with knee pain receiving HRT were enrolled into this open-label, randomized, controlled study. Subjects were randomized into Group 1 (n= 24) or Group 2 (n=24). Subjects in Group 1 were given 3 months open treatment with calcium (260 mg/day) as adjunctive therapy combined with HRT. Group 2 received PPE (9 capsules/day) as adjunctive therapy combined with HRT. Changes in the degree of knee pain were evaluated by the Visual Analog Scale (VAS). RESULTS: Treatment with PPE was significantly effective in reducing the VAS score for knee pain at 4 weeks (p < 0.05), at 8 weeks (p< 0.01) and at 12 weeks (p<0.01), compared with the control group. Interestingly, the effects continued for 4 weeks after cessation of treatment in the PPE group (p< 0.01) compared with the control group. The PPE treatment had no significant adverse effects on blood biochemical and metabolic profiles, especially related to the risk factors for cardiovascular disease. CONCLUSION: PPE is a possible option as an adjunctive oral supplement in the case of HRT-resistant, long-lasting knee pain.


Subject(s)
Arthralgia , Calcium Compounds/administration & dosage , Hormone Replacement Therapy/methods , Knee Joint , Osteoporosis, Postmenopausal , Placental Extracts , Aged , Animal Structures , Animals , Arthralgia/blood , Arthralgia/diagnosis , Arthralgia/etiology , Arthralgia/therapy , Drug Monitoring , Drug Resistance , Drug Therapy, Combination , Female , Humans , Knee Joint/drug effects , Knee Joint/metabolism , Knee Joint/physiopathology , Middle Aged , Osteoporosis, Postmenopausal/blood , Osteoporosis, Postmenopausal/complications , Pain Measurement , Placental Extracts/administration & dosage , Placental Extracts/adverse effects , Swine/anatomy & histology , Treatment Outcome
20.
J Indian Med Assoc ; 108(2): 117-8, 122, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20839572

ABSTRACT

Combination of placentrex injection with antimicrobial therapy is a better option for treating pelvic inflammatory disease (PID) than only antimicrobial therapy; which also gives more sustained effect and lesser recurrences. Improvements in symptoms continue despite stopping therapy. Addition of placentrex leads to marked improvement in dyspareunia, less fornix tenderness and better uterine mobility suggesting better effect on adnexal tissues and parametrium. As placentrex decreases adnexal inflammation to significant level in comparison to antimicrobials alone, it can be a good option- specially to reduce the risk of tubal damage, infertility and formation of adnexal mass. In a study of 100 cases of PID, 50 in group I and II each; 42 in group 1 and 32 in group II completed the study. Marked reduction in various symptoms was observed in study group I (27-59%) where as in group II where only antimicrobial was given, reduction was found in range of 12-48%. Thus overall, group I had better as well as sustained effect of therapy on relieving dyspareunia, fornix tenderness and uterine restricted mobility which was statistically significant. In other symptoms and signs, there was marginal efficacy except in cervical erosion where no improvement was observed.


Subject(s)
Pelvic Inflammatory Disease/drug therapy , Placental Extracts/therapeutic use , Adult , Anti-Bacterial Agents/therapeutic use , Female , Humans , Injections , Middle Aged , Placental Extracts/administration & dosage , Prospective Studies , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...